TrialPloS one2011

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.

James S Cavenaugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.